Kristofer Svensson
Directeur Financier/CFO chez GABATHER AB
Postes actifs de Kristofer Svensson
Sociétés | Poste | Début | Fin |
---|---|---|---|
GABATHER AB | Directeur Financier/CFO | - | - |
BIOEXTRAX AB | Directeur Financier/CFO | 01/01/2023 | - |
ECTIN RESEARCH AB | Directeur Financier/CFO | - | - |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Directeur Financier/CFO | 01/05/2022 | - |
Sinfonia Biotherapeutics AB
Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden. | Directeur Financier/CFO | 01/01/2022 | - |
Historique de carrière de Kristofer Svensson
Anciens postes connus de Kristofer Svensson
Sociétés | Poste | Début | Fin |
---|---|---|---|
SENSIDOSE AB | Directeur Financier/CFO | 01/04/2017 | 01/10/2022 |
Formation de Kristofer Svensson
University of Stockholm | Graduate Degree |
Statistiques
Internationale
Suède | 8 |
Opérationnelle
Director of Finance/CFO | 6 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
GABATHER AB | Health Technology |
BIOEXTRAX AB | Health Technology |
SENSIDOSE AB | Electronic Technology |
ECTIN RESEARCH AB | Health Technology |
Entreprise privées | 2 |
---|---|
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Health Technology |
Sinfonia Biotherapeutics AB
Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden. | Health Technology |
- Bourse
- Insiders
- Kristofer Svensson
- Expérience